Search results
Moderna's New RSV Vaccine Undercuts the Promise of mRNA
Bloomberg via Yahoo Finance· 3 hours ago(Bloomberg) -- Moderna Inc.’s pioneering Covid shot turned the company into a nearly $200 billion...
AstraZeneca withdrawing Covid vaccine, months after admitting rare side effect
The Telegraph via Yahoo News· 2 days agoThe Oxford-AstraZeneca Covid vaccine is being withdrawn worldwide, months after the pharmaceutical...
Moderna’s sales from its only product, the COVID-19 vaccine, fell 91% from last year
Fortune via Yahoo Finance· 7 days agoThe dark days of the pandemic are finally in the past for most of us—and that seems to be reflected...
Moderna, Inc. (NASDAQ:MRNA) Q1 2024 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 5 days agoModerna, Inc. (NASDAQ:MRNA) Q1 2024 Earnings Call Transcript May 2, 2024 Moderna, Inc. beats...
Moderna reports $1.2bn net loss in Q1 2024
Pharmaceutical Technology via Yahoo Finance· 6 days agoModerna experienced a substantial financial shift in the first quarter (Q1) of 2024, reporting a net loss of $1.2bn - a stark contrast to its net income...
Q1 2024 CytomX Therapeutics Inc Earnings Call
Thomson Reuters StreetEvents via Yahoo Finance· 1 hour agoStrategic...Myers Squibb, Amgen, Astellas, Regeneron and Moderna on multiple Probody therapeutic programs. We continue to be in a strong financial...
Will withdrawal of AstraZeneca vaccine affect your next COVID booster jab?
Yahoo News UK· 23 hours agoThe guidance said that only mRNA Pfizer or Moderna vaccines would be used in the booster programme....
Was COVID vaccine recalled over health danger fears? What we know
Newsweek· 58 minutes agoPharmaceutical company AstraZeneca has initiated a global withdrawal of its COVID-19 vaccine just...
AstraZeneca: What are the rare side effects of the Covid jab?
The Independent via Yahoo News· 1 day agoHowever, the government largely stopped using the jab and it was replaced in the UK with Pfizer and ...
CytomX Therapeutics Inc (CTMX) Q1 2024 Earnings Call Transcript
Guru Focus· 1 day agoCytomX Therapeutics Inc (CTMX, Financial) announced positive initial Phase 1a dose escalation data for CX nine oh four, showing promising anti-cancer activity, particularly ...
